UBS Group »

C4 Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 278k 5.65
2023-09-30 $598k 322k 1.86
2023-06-30 $742k 270k 2.75
2023-03-31 $511k 163k 3.14
2022-12-31 $1.6M 270k 5.90
2022-09-30 $2.8M 317k 8.73
2022-06-30 $2.8M 377k 7.53
2022-03-31 $8.0M 330k 24.25
2021-12-31 $11M 343k 32.20
2021-09-30 $19M 417k 44.68
2021-06-30 $15M 401k 37.87
2021-03-31 $9.7M 262k 36.99
2020-12-31 $3.3M 101k 32.93